Systemic inflammatory response syndrome caused by chronic salicylate intoxication

Southern Medical Journal

Volumn 89, Issue 5, 1996, Pages 479-482

  Chalasani, Naga ^a   Roman, Jesse ^a   Jurado, Rafael L ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALI; ANTIBIOTIC AGENT; SALICYLIC ACID; SALSALATE;

ADULT; ARTICLE; BODY TEMPERATURE DISORDER; BRAIN DISEASE; CASE REPORT; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG BLOOD LEVEL; EARLY DIAGNOSIS; FEMALE; HOSPITALIZATION; HUMAN; HYPERVENTILATION; HYPOTENSION; INFLAMMATION; INTOXICATION; LEUKOCYTOSIS; LEUKOPENIA; LUNG EDEMA; MALE; METABOLIC ACIDOSIS; ORAL DRUG ADMINISTRATION; SEPSIS; TACHYCARDIA; TACHYPNEA; URINE PH;

ACID-BASE IMBALANCE; ADULT; ANTI-ARRHYTHMIA AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHRONIC DISEASE; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; FEVER; HUMANS; HYPOTENSION; MALE; MIDDLE AGED; PULMONARY EDEMA; SALICYLIC ACID; SALICYLIC ACIDS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0030007459     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199605000-00005     Document Type: Article

References (29)

1. Rangel-Frausto MS, Pittet D, Costigan M, et al: The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995; 273:117-123
2. American College of Chest Physicians, Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-875
3. Bone RC, Fischer CJ, Clemmer TP, et al, and Methyl Prednisolone Severe Sepsis Study Group: A controlled trial of high dose methyl prednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987; 317:653-658
4. Dinarello CA, Gelfand JA, Woff SM: Anticytokine strategies in the treatment of the systemic inflammatorv response syndrome. JAMA 1993; 269:1829-1835
5. Okusawa S, Gelfand JA, Ikejima T, et al: Interleukin-1 induces a shock-like state in rabbits: synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest 1988; 81:1162-1172
6. Tracey KJ, Fong Y, Hesse DG, et al: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 1987; 330:662-664
7. Light RB: Sepsis syndrome. Principles of Critical Care Hall JB, Schmidt GA, Wood LDH (eds). New York, McGraw-Hill, 1992, pp 645-655
8. Leatherman JW, Schmitz PG. Fever, hyperdynamic shock, and multiple system organ failure. Chest 1991; 100.1391-1396
9. Pei YPC, Thompson DA: Severe salicylate intoxication mimicking septic shock (Letter). Am J Med 1987; 82:381-382
10. Anderson RJ, Potts DE, Gabow PA, et al: Unrecognized adult salicylate intoxications. Ann Intern Med 1976; 35:715
11. Needs CJ, Brooks PM: Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet 1985; 10:161-177
12. Temple AR: Acute and chronic effects of aspirin toxicity and their treatment. Arch Intern Med 1981; 141:364-369
13. Matuschack GM: Pseudosepsis syndrome, multiple system organ failure and chronic salicylate intoxication: inhibition of regulatory eicosanoids (Editorial Comments). Chest 1991; 100:1188-1189
14. Lee TH: Mechanisms of aspirin sensitivity. Am Rev Respir Dis 1992; 145:S34-S36
15. 4: a potent chemotactic and aggregating substance released from PMN leukocytes. Nature 1980; 286:264
16. Stenson WF, Parker CW: Monohydroxyeicosatetraenoic acids (HETEs) induce degranulation of human neutrophils. J Immunol 1980; 124:2100-2104
17. 4 on protein permeability in sheep lung. Fed Proc 1985; 44:30-35
18. 4 induces lung injury in the rabbit: role of neutrophils and effect of indomethacin. J Appl Physiol 1993; 74:2174-2179
19. Ogletree ML, Oates JA, Brigham KL et al: Evidence for pulmonary release of 5-HETE during endotoxemia in unanesthetized sheep. Fed Proc 1982; 2:59-68
20. Olson NC, Dobrowsky RT, Fleisher LN: Hydroxyeicosatetraenoic acids are increased in bronchoalveolar lavage fluid of endotoxemic pigs. Prostagtandins 1987; 34:493-503
21. 4 in pulmonary edema fluid of patients with adult respiratory distress syndrome. J Clin Immunol 1984; 8:479-484
22. Stephenson AH, Lonigro AJ, Hyers TM, et al: Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk for ARDS. Am Rev Respir Dis 1988; 138:714-719
23. 2. J Lipid Mediat 1993; 6:175-181
24. Marcinkiewicz J, Chain BM: Differential cytokine regulation by eicosanoids in T cells primed by contact sensitization with TNP. Cell Immunol 1993; 149:303-314
25. 4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991; 143:1025-1029
26. Lorenzet R, Niemetz J, Marcus AJ, et al: Enhancement of mononuclear procoagulant activity by platelet 12-hydroxyeicosatetraenoic acid. J Clin Invest 1986; 78:418-123
27. Slotman GJ, Burchard KW, D'Arezzo A, et al: Ketoconazole prevents acute respiratory failure in critically ill surgical patients. J Trauma 1988; 28:648-654
28. Marinelli WA, Henke CA, Harmon KR, et al: Mechanisms of alveolar fibrosis after acute lung injury. Clin Chest Med 1990; 11:657-672
29. Walters JS, Woodring JH, Stelling CB, et al: Salicylate-induced pulmonary edema. Radiology 1983; 146:289-293